OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet's Disease with Oral Ulcers

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet's Disease with Oral Ulcers